5 completed, 5 recruiting, 1 active not recruiting, 1 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Dent Disease: new trials by email Literature Review of Dent Disease trials Research Report on Dent Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrasound for Socket Healing Evaluation Healing Wound, Alveolar; Wound | Active not recruiting | University of Michigan | 140 | 2024-07-25 | 2026-09-14 | |
| Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics Salivary samples - Dent Disease | Completed | Assistance Publique - Hôpitaux de Paris | 41 | 2020-06-03 | 2023-11-21 | |
| Monogenic Kidney Stone - Genetic Testing Rare Kidney Stone Diseases | Recruiting | Mayo Clinic | 6000 | 2017-09-11 | 2026-04-13 | |
| Prospective Research Rare Kidney Stones (ProRKS) Hyperoxaluria, Cystinuria | Recruiting | Mayo Clinic | 220 | 2016-05-01 | 2026-08-07 | |
| Role Of Phosphorus And FGF 23 In Patients With Dent Disease Phosphorus Supplement, Observation - Dent Disease | Phase 1 / Phase 2 | Completed | Mayo Clinic | 30 | 2014-09-01 | 2020-03-23 |
| Review of Kidney Biopsies of Dent Disease Patients Renal Biopsy - Dent Disease | Completed | Mayo Clinic | 20 | 2013-10-01 | 2015-09-22 | |
| Health-related Quality of Life in Rare Kidney Stone Health-related Quality of Life in Rare Kidney Stone Questionnaire - Primary Hyperoxaluria, Cystinuria | Completed | NYU Langone Health | 365 | 2013-08-01 | 2022-09-02 | |
| Rare Kidney Stone Consortium Biobank Primary Hyperoxaluria, Dent Disease | Recruiting | Mayo Clinic | 2000 | 2013-05-01 | 2026-07-22 | |
| Dent Disease Mutation Genotyping Genetic Analysis - Dent Disease | Not applicable | Completed | Mayo Clinic | 180 | 2012-08-01 | 2020-04-06 |
| National Registry of Rare Kidney Diseases Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis | Recruiting | UK Kidney Association | 35000 | 2009-11-06 | 2023-10-04 | |
| Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria Hydrochlorothiazide - Dent's Disease, Nephrolithiasis | Phase 2 / Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 10 | 2003-07-01 | 2008-03-19 |
| Rare Kidney Stone Consortium Patient Registry Primary Hyperoxaluria, Dent Disease | Recruiting | Mayo Clinic | 730 | 2003-07-01 | 2026-07-10 |
Adenine phosphoribosyltransferase deficiency (6) · Cystinuria (6) · Hyperoxaluria, Primary (6) · Hyperoxaluria (4) · Oculocerebrorenal Syndrome (2) · Alveolar Bone Loss (1) · Atypical Hemolytic Uremic Syndrome (1) · Bartter Syndrome (1) · Calciphylaxis (1) · Cystinosis (1) · Denys-Drash Syndrome (1) · Diabetes Insipidus, Nephrogenic (1) · Fabry Disease (1) · Fibromuscular Dysplasia (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genetic Diseases, Inborn (12) · Genetic Diseases, X-Linked (12) · Kidney Diseases (12) · Male Urogenital Diseases (12) · Renal Tubular Transport, Inborn Errors (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Carbohydrate Metabolism, Inborn Errors (6) · Metabolic Diseases (6) · Metabolism, Inborn Errors (6) · Nutritional and Metabolic Diseases (6) · Renal Aminoacidurias (6)
Genetic Testing (1) · Hydrochlorothiazide (1) · Observation (1) · Quality of Life (1)
Mayo Clinic (7) · Assistance Publique - Hôpitaux de Paris (2) · NYU Langone Health (1) · UK Kidney Association (1) · University of Michigan (1)
United States (9) · Iceland (3) · France (2) · Canada (1) · Israel (1) · United Kingdom (1)
John C Lieske, M.D. (3) · David Goldfarb, MD (2) · David Sas, DO (1) · Dawn S. Milliner, M.D. (1) · John C Lieske, MD (1) · John C. Lieske, MD (1) · John Lieske, MD (1) · Oliver Kripfgans, PhD (1) · Vidar Edvardsson, MD (1)
U54DK083908 (4), R01DE030872 (1)